Tech excites us – and if you’re taking your business to the next level through tech transactions, you need our knowledge of the technology itself as well as corporate expertise. Your company will be more successful when it maximises the value of technology and IP – a cornerstone of our practice.

To succeed in today’s fast-paced business environment you need advisers that bring a commercial outlook and market perspective from the get-go. Our focus on pre and post-transaction aspects such as planning and post-merger integration leave no stone unturned.

We believe in practical, proactive advice with a personal touch. Our 200 lawyers across Europe, Asia and the Middle East advise on all forms of corporate finance from private and public M&A, to private equity, IPOs and joint ventures together with all of the corporate governance and company advice needed.

We use tech solutions to underpin smart, useful advice that benefits our clients – not for the sake of it.

Whatever your size, stage in lifecycle or sector you’ll benefit from having our talented deal-makers onboard.

If you would like to know more about working with us, please contact Co-Heads Peter Veranneman in Germany and Alberto Salvade in Italy. 

 

Recent highlights of work

  • Advised Darktrace, the machine-learning cyber security company, on its latest investment which tipped the company's value over the magical $1USD billion mark ($USD 1.25 billion), making it the firm's latest Unicorn.
  • Advised as Singapore counsel to Clearbridge Health, a medtech investor, on the proposed initial public offering of 88 million shares at 28 cents each on the Catalist board of the Singapore Exchange to raise net proceeds of S$21.4 million to build a business focused on precision medical services.
  • Advised US life sciences company Unchained Labs on the acquisition of German rap.ID Particle Systems GmbH. The transaction was managed in only four weeks, including due diligence, negotiations and notarization of the share purchase agreements with a focus on intellectual property rights. In connection with this transaction, Unchained Labs raised $17 million in a series D financing. Novo Ventures, Canaan Partners, TPG Biotech and Tri-Valley Ventures all participated in the financing.

Accolades

  • Band 1 in Hungary for Commercial, Corporate and M&A

    Legal 500 2018 EMEA

  • Band 1 listing for Cuba: Corporate/Commercial: Lawyers Based Abroad

    Chambers 2017 Latin America

  • Band 1 listing: Corporate and commercial – commercial contracts and Corporate and commercial – Venture capital

    Legal 500 2017 UK

  • Experienced AIM group capable of advising on IPOs, secondary fund-raisings and M&A transactions.

    Chambers UK 2017

  • The team continues to impress with its core of dedicated corporate practitioners with a niche expertise in the TMT and life sciences industries.

    Chambers Asia-Pacific

  • “… makes full use of its global network and full-service approach to provide a strong M&A practice.”

    Chambers Europe

  • ‘’One of the team’s strengths is that the lawyers have clear specialisations, and are very knowledgeable in their respective fields’’.

    Chambers Europe

  • Well versed in cross-border transactions in the TMT, healthcare, and energy and utilities sectors. Impressive client roster includes a number of highly active fast-growth companies.

    Chambers UK

  • Bird & Bird’s ‘strengths are industry knowledge, fast responses and competence’.

    Legal 500 EMEA

Related materials and downloads

News & Events

  1. 0304-2020

    COVID-19 in Germany: Legal obligations of managing directors in the corona crisis

    The COVID-19 pandemic is increasingly having a significant impact on the economy and companies. In connec-tion with the crisis, managing directors of limited liability companies (GmbH) are confronted with a wide range ...

  2. 0104-2020

    FIRB update: Reducing the monetary thresholds and extending the review period

    On 29 March 2020 the Treasurer announced two significant changes to Australia's foreign investment rules. The changes are effectively immediately (but will not apply to transactions entered into before 10.30pm on 29 ...

  3. 0104-2020

    Temporary Relief for Inability to Perform Contractual Obligations due to the COVID-19 Situation in Singapore

    The COVID-19 pandemic and associated public health measures imposed by government around the world has had unprecedented and unforeseeable impact, including supply chain disruptions and manpower shortages, undermining ...

  1. 1803-2020

    Two notable fundraisings in one week

    Working through unprecedented market turbulence, the London Capital Markets Team is proud to have advised on two notable fundraisings on the LSE's Aim Market, which closed within the past week.

  2. 2802-2020

    Bird & Bird advises Mitsubishi Chemical Corporation on the acquisition of c-m-p

    International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...

  3. 3001-2020

    Bird & Bird advised Sapiens on the acquisition of sum.cumo

    Bird & Bird LLP advised Sapiens International Corporation, a leading global provider of software solutions for the insurance industry, on the up to €28.4 million acquisition of sum.cumo GmbH, a German-based technology ...

View More Firm News

There are no forthcoming events for this area. Please click on the button below to view past events.

View more events